8-K - ADC Therapeutics SA (0001771910) (Filer)
Published . Updated .
Filed: 2026-10-13 AccNo: 0000950103-26-015465 Size: 808 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
Directly affected
- ADCT ADC Therapeutics
Named in this report.
Indirectly affected
- BBOT BRIDGEBIO ONCOLOGY THERAPEUTIC
GA selected BBOT as a RELATED security because its canonical security name directly matches this event's themes: therapeutics, oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- CRDF CARDIFF ONCOLOGY INC COM
GA selected CRDF as a RELATED security because its canonical security name directly matches this event's themes: oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-13 AccNo: 0000950103-26-015465 Size: 808 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financi…
Source: sec-edgar
ADC Therapeutics (ADCT) since “8-K - ADC Therapeutics SA (0001771910) (Filer),” compared with the market
Since the first closing price after “8-K - ADC Therapeutics SA (0001771910) (Filer),” ADC Therapeutics (ADCT) is -0.69%. The S&P 500 fund (SPY) is -0.40% over the same days, a -0.29% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Acadia Healthcare (ACHC) | that day | +0.50% | final price |
| Acadia Healthcare (ACHC) | the next day | +5.29% | final price |
| Acadia Healthcare (ACHC) | two days later | +3.19% | final price |
| Acadia Healthcare (ACHC) | three days later | -0.33% | final price |
| Acadia Healthcare (ACHC) | three days earlier | -5.32% | final price |
| Acadia Healthcare (ACHC) | five days earlier | -3.46% | final price |
| ADC Therapeutics (ADCT) | that day | -8.60% | final price |
| ADC Therapeutics (ADCT) | the next day | -22.04% | final price |
| ADC Therapeutics (ADCT) | two days later | -20.16% | final price |
| ADC Therapeutics (ADCT) | three days later | -24.73% | final price |
| ADC Therapeutics (ADCT) | three days earlier | -14.78% | final price |
| ADC Therapeutics (ADCT) | five days earlier | -31.99% | final price |
| Ascendis Pharma A/S (ASND) | that day | -1.62% | final price |
| Ascendis Pharma A/S (ASND) | the next day | +0.04% | final price |
| Ascendis Pharma A/S (ASND) | two days later | -0.14% | final price |
| Ascendis Pharma A/S (ASND) | three days later | -0.76% | final price |
| Ascendis Pharma A/S (ASND) | three days earlier | -1.88% | final price |
| Ascendis Pharma A/S (ASND) | five days earlier | -0.35% | final price |
| aTYR PHARMA (ATYR) | that day | -7.79% | final price |
| aTYR PHARMA (ATYR) | the next day | -16.23% | final price |
| aTYR PHARMA (ATYR) | two days later | -14.52% | final price |
| aTYR PHARMA (ATYR) | three days later | -18.17% | final price |
| aTYR PHARMA (ATYR) | three days earlier | +18.40% | final price |
| aTYR PHARMA (ATYR) | five days earlier | +30.15% | final price |
| BridgeBio Pharma (BBIO) | that day | -3.73% | final price |
| BridgeBio Pharma (BBIO) | the next day | -1.23% | final price |
| BridgeBio Pharma (BBIO) | two days later | +2.10% | final price |
| BridgeBio Pharma (BBIO) | three days later | +0.97% | final price |
| BridgeBio Pharma (BBIO) | three days earlier | -1.08% | final price |
| BridgeBio Pharma (BBIO) | five days earlier | +1.84% | final price |
Disclosure records for ADC Therapeutics (ADCT) within two months of 13 Oct 2026
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around ADC Therapeutics (ADCT)
Companies carried with this story
- ADCT ADC Therapeutics
For “8-K - ADC Therapeutics SA (0001771910) (Filer),” ADC Therapeutics (ADCT) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ADCT
- BBOT BridgeBio Oncology Therapeutics
For “8-K - ADC Therapeutics SA (0001771910) (Filer),” BridgeBio Oncology Therapeutics (BBOT) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBOT as a RELATED security because its canonical security name directly matches this event's themes: therapeutics, oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ACHC Acadia Healthcare
For “8-K - ADC Therapeutics SA (0001771910) (Filer),” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
For “8-K - ADC Therapeutics SA (0001771910) (Filer),” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CRDF Cardiff Oncology
For “8-K - ADC Therapeutics SA (0001771910) (Filer),” Cardiff Oncology (CRDF) is linked, with no stored direction, medium confidence. Reason on file: GA selected CRDF as a RELATED security because its canonical security name directly matches this event's themes: oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
For “8-K - ADC Therapeutics SA (0001771910) (Filer),” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
For “8-K - ADC Therapeutics SA (0001771910) (Filer),” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - ADC Therapeutics SA (0001771910) (Filer)” reaches ADC Therapeutics (ADCT)
On 13 Oct 2026, “8-K - ADC Therapeutics SA (0001771910) (Filer)” is the story that connects ADC Therapeutics (ADCT) to this story.
What ties ADC Therapeutics (ADCT) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> ADCT
Also listed, BridgeBio Oncology Therapeutics (BBOT): GA selected BBOT as a RELATED security because its canonical security name directly matches this event's themes: therapeutics, oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for ADC Therapeutics (ADCT)
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ADCT traded between 1.03 and 1.83 across 16 sessions. The latest close on file is 1.44. BBOT traded between 2.79 and 9.14 across 14 sessions. The latest close on file is 2.84.
How solid “8-K - ADC Therapeutics SA (0001771910) (Filer)” looks
46 out of 100
“8-K - ADC Therapeutics SA (0001771910) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.